Correction: Tislelizumab in Chinese patients with advanced solid tumors: an open-label, non-comparative, phase 1/2 study
oleh: Yu-Pei Chen, Ya-Qin Wang, Yan-Ping Mao, Ying-Qing Li, Shuo-Yu Xu, Xiao-Min Li, Qing-Mei He, Shi-Wei He, Xiao-Jing Yang, Yuan Lei, Yin Zhao, Jing-Ping Yun, Yingqin Li
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2020-07-01 |
Deskripsi
No description available for this item.